Tags

Type your tag names separated by a space and hit enter

BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Natl Cancer Inst Monogr. 1973 Dec; 39:165-75.NC

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

4595314

Citation

Mathé, G, et al. "BCG in Cancer Immunotherapy: Experimental and Clinical Trials of Its Use in Treatment of Leukemia Minimal and or Residual Disease." National Cancer Institute Monograph, vol. 39, 1973, pp. 165-75.
Mathé G, Weiner R, Pouillart P, et al. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Natl Cancer Inst Monogr. 1973;39:165-75.
Mathé, G., Weiner, R., Pouillart, P., Schwarzenberg, L., Jasmin, C., Schneider, M., Hayat, M., Amiel, J. L., de Vassal, F., & Rosenfeld, C. (1973). BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. National Cancer Institute Monograph, 39, 165-75.
Mathé G, et al. BCG in Cancer Immunotherapy: Experimental and Clinical Trials of Its Use in Treatment of Leukemia Minimal and or Residual Disease. Natl Cancer Inst Monogr. 1973;39:165-75. PubMed PMID: 4595314.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. AU - Mathé,G, AU - Weiner,R, AU - Pouillart,P, AU - Schwarzenberg,L, AU - Jasmin,C, AU - Schneider,M, AU - Hayat,M, AU - Amiel,J L, AU - de Vassal,F, AU - Rosenfeld,C, PY - 1973/12/1/pubmed PY - 1973/12/1/medline PY - 1973/12/1/entrez SP - 165 EP - 75 JF - National Cancer Institute monograph JO - Natl Cancer Inst Monogr VL - 39 SN - 0083-1921 UR - https://www.unboundmedicine.com/medline/citation/4595314/BCG_in_cancer_immunotherapy:_experimental_and_clinical_trials_of_its_use_in_treatment_of_leukemia_minimal_and_or_residual_disease_ L2 - https://medlineplus.gov/chroniclymphocyticleukemia.html DB - PRIME DP - Unbound Medicine ER -